VC-backed Codiak Biosciences goes public
Codiak Biosciences Inc, a developer of exosome-based therapeutics, has raised about $82.5 million for its IPO after pricing its 5.5 million shares at $15 per share.
14 October 2020•3 mins read
Codiak Biosciences Inc, a developer of exosome-based therapeutics, has raised about $82.5 million for its IPO after pricing its 5.5 million shares at $15 per share.
